Skip to main content
Erschienen in: Clinical Research in Cardiology 9/2021

28.01.2021 | Original Paper

Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis

verfasst von: Laurent Fauchier, Arnaud Bisson, Alexandre Bodin, Julien Herbert, Denis Angoulvant, Nicolas Danchin, Yves Cottin

Erschienen in: Clinical Research in Cardiology | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

In patients with acute myocardial infarction (AMI), history of atrial fibrillation (AF) and new onset AF during the early phase may be associated with a worse prognosis. Whether both conditions are associated with similar outcomes is a matter of debate.

Methods

We collected information for all patients with AMI seen in French hospitals between 2010 and 2019. Among 797,212 patients seen with STEMI or NSTEMI, 75,701 (9.5%) had history of AF, and 34,768 (4.4%) had new AF diagnosed between day 1 and day 30 after AMI.

Results

Patients with new AF were older and had more comorbidities than those with no AF but were younger and had less comorbidities than those with history of AF. During follow-up [mean (SD) 1.8 (2.4) years, median (interquartile range) 0.7 (0.1–3.1) years], 163,845 deaths and 30,672 ischemic strokes were recorded. Using Cox multivariable analysis, compared to patients with no AF, history of AF was associated with a higher risk of death during follow-up (adjusted hazard ratio HR 1.17, 95% CI 1.16–1.19) and this was also the case for patients with new AF (adjusted HR 2.11, 2.07–2.15). Both history of AF and new AF were associated with a higher risk of ischemic stroke compared to patients with no AF: adjusted HR 1.19 (1.15–1.23) for history of AF, adjusted HR 1.78 (1.68–1.88) for new AF. New AF was associated with a higher risk of death and of ischemic stroke than history of AF: adjusted HR 1.74 (1.70–1.79) and 1.32 (1.23–1.42), respectively.

Conclusions

In a large and systematic nationwide analysis, AF first recorded in the first 30 days after AMI was independently associated with higher risks of death and ischemic stroke than those in patients with no AF or previously known AF.

Graphic abstract

Literatur
6.
Zurück zum Zitat Djennaoui M, Ficheur G, Beuscart R, Chazard E (2015) Improvement of the quality of medical databases: data-mining-based prediction of diagnostic codes from previous patient codes. Stud Health Technol Inform 210:419–423PubMed Djennaoui M, Ficheur G, Beuscart R, Chazard E (2015) Improvement of the quality of medical databases: data-mining-based prediction of diagnostic codes from previous patient codes. Stud Health Technol Inform 210:419–423PubMed
7.
Zurück zum Zitat Bezin J, Pariente A, Lassalle R, Dureau-Pournin C, Abouelfath A, Robinson P, Moore N, Droz-Perroteau C, Fourrier-Reglat A (2014) Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol 70(4):429–436. https://doi.org/10.1007/s00228-013-1614-5CrossRefPubMed Bezin J, Pariente A, Lassalle R, Dureau-Pournin C, Abouelfath A, Robinson P, Moore N, Droz-Perroteau C, Fourrier-Reglat A (2014) Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol 70(4):429–436. https://​doi.​org/​10.​1007/​s00228-013-1614-5CrossRefPubMed
8.
Zurück zum Zitat Massoullié G, Wintzer-Wehekind J, Chenaf C, Mulliez A, Pereira B, Authier N, Eschalier A, Clerfond G, Souteyrand G, Tabassome S, Danchin N, Citron B, Lusson JR, Puymirat É, Motreff P, Eschalier R (2016) Prognosis and management of myocardial infarction: comparisons between the French FAST-MI 2010 registry and the French public health database. Arch Cardiovasc Dis 109(5):303–310. https://doi.org/10.1016/j.acvd.2016.01.012CrossRefPubMed Massoullié G, Wintzer-Wehekind J, Chenaf C, Mulliez A, Pereira B, Authier N, Eschalier A, Clerfond G, Souteyrand G, Tabassome S, Danchin N, Citron B, Lusson JR, Puymirat É, Motreff P, Eschalier R (2016) Prognosis and management of myocardial infarction: comparisons between the French FAST-MI 2010 registry and the French public health database. Arch Cardiovasc Dis 109(5):303–310. https://​doi.​org/​10.​1016/​j.​acvd.​2016.​01.​012CrossRefPubMed
11.
Zurück zum Zitat Laurent G, Dentan G, Moreau D, Zeller M, Laurent Y, Vincent-Martin M, Lhuillier I, Makki H, Wolf JE, Cottin Y (2005) Atrial fibrillation during myocardial infarction with and without ST segment elevation. Arch Mal Coeur Vaiss 98(6):608–614PubMed Laurent G, Dentan G, Moreau D, Zeller M, Laurent Y, Vincent-Martin M, Lhuillier I, Makki H, Wolf JE, Cottin Y (2005) Atrial fibrillation during myocardial infarction with and without ST segment elevation. Arch Mal Coeur Vaiss 98(6):608–614PubMed
16.
Zurück zum Zitat Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K (2019) 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace Eur Pacing Arrhythmias Cardiac Electrophysiol J Work Groups Cardiac Pacing Arrhythmias Cardiac Cell Electrophysiol Eur Soc Cardiol 21(2):192–193. https://doi.org/10.1093/europace/euy174CrossRef Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K (2019) 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace Eur Pacing Arrhythmias Cardiac Electrophysiol J Work Groups Cardiac Pacing Arrhythmias Cardiac Cell Electrophysiol Eur Soc Cardiol 21(2):192–193. https://​doi.​org/​10.​1093/​europace/​euy174CrossRef
Metadaten
Titel
Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis
verfasst von
Laurent Fauchier
Arnaud Bisson
Alexandre Bodin
Julien Herbert
Denis Angoulvant
Nicolas Danchin
Yves Cottin
Publikationsdatum
28.01.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 9/2021
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-021-01805-2

Weitere Artikel der Ausgabe 9/2021

Clinical Research in Cardiology 9/2021 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.